' The Company retains flexibility to vary its cash commitment to biomass, and the source of its funding for this investment, as part of its growth planning to align biomass levels with sales objectives.'
They don't or may not need to continue with the current level of biomass investment.
They have flexibility in the source of funding i.e internal funding, debt, equity.
Biomass growth is being aligned with anticipated sales i.e an investment in future sales growth.
Biomass growth is currently running at approx a third more than sales growth (2,750 tonnes growth 3 qtrs vs sales forecast fy) with sales growing at approx 25%. This disparity won't continue indefinitely as a substantial part of the biomass growth is the expansion growth of frylings taking up to 2 years to reach sales size. Once the expansion stock reach sales size the biomass investment will fall until they decide to expand other leases.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
CSS
clean seas seafood limited
Add to My Watchlist
0.00%
!
13.5¢

' The Company retains flexibility to vary its cash commitment to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.28M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $18.51K | 137.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4127350 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 6763916 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4127350 | 0.135 |
3 | 77222 | 0.130 |
1 | 7200 | 0.125 |
1 | 7500 | 0.120 |
1 | 7826 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 6763916 | 25 |
0.145 | 68473 | 1 |
0.150 | 7500 | 2 |
0.155 | 8000 | 1 |
0.200 | 7760 | 1 |
Last trade - 15.40pm 27/06/2025 (20 minute delay) ? |
Featured News
CSS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online